Mirimus is guided by the leadership of medical specialists, senior scientists, and experienced managers, all of whom understand the unique demands and privileges of working to improve the health of patients. We are continually working to improve the range, accuracy, and convenience of our testing services to empower healthcare professionals and patients to make the best decisions.
In 2020, when COVID-19 hit New York City and it became the epicenter of the pandemic, Mirimus committed its resources to support the fight against COVID-19 and developed a pioneering high-volume saliva-based COVID-19 PCR testing approach called SalivaClear®, performing 4 million tests and servicing hundreds of schools, businesses, and government organizations across the country. SalivaClear won the XPRIZE in 2021, the world’s leading competition to solve humanity’s grand challenges.
Test your population in pools of up to 8 people at regular frequency to detect the presence of infection.
A detected positive pool is tested in smaller pools of 2 samples to isolate the infection of two people.
A positive pool of 2 samples are reflex tested as 2 diagnostic tests to identify the infected individual.
Since the pandemic, waking up with a ticke in your throat and a stuffy nose can cause alarm. Is it COVID-19? Is it the flu? Early and accurate diagnosis of infections has never been more critical. Our highly accurate PCR test uses a single shallow nasal swab to give you all the answers you need. With results available within 24 hours of sample receipt at our lab, you can have peace of mind and quick acccess to proper treatment. Our PCR test is especially beneficial for nursing homes as they often house people with underlying health conditions, who are at higher risk of severe illness from COVID-19 and influenza. By testing regularly, nursing homes can quickly identify and isolate infected individuals to prevent further spread of the viruses, keeping residents, staff, and visitors safe.
Protecting yourself against COVID-19 is more than just getting vaccinated. Immune Index™ is the ultimate clinical tool for monitoring your immune status against COVID-19 in real-time. With just a simple finger prick, you can get highly accurate results on your neutralizing antibodies, helping you make informed decisions regarding vaccination and close-contact exposure. Our cutting-edge technology provides doctors and patients with a wealth of valuable information, including advising individuals to receive vaccination booster in high-risk groups, or defer in high immunity cases to minimize the risk of complications. With regular monitoring every 6 months, Immune Index™ supports optimal management of patient care.
When it comes to urinary tract infections (UTIs), accurate diagnosis is crucial to avoid long-lasting pain and discomfort, chronic infections, kidney damage, and even life-threatening sepsis. But traditional urine culture diagnosis can be slow and inaccurate, leading to delayed treatment and poor outcomes. That's where our UTI PCR Test comes in. Our comprehensive report provides all the information your physician needs to make informed decisions about your treatment plan. You'll get detailed information on the pathogens detected, their load percentage, and the antibiotic classification for each gene, allowing for personalized treatment plans that are tailored to your specific needs. What's more, our test is unaffected by concurrent antibiotic use, so you can get accurate results no matter when you take the test.
No two people are alike, nor is their response to medication. EffectiveRX test analyzes how individual's genes affect their response to certain medications, allowing healthcare providers to personalize medication regimens. For older adults who take multiple medications, EffectiveRX is a powerful tool for improving treatment outcomes and reducing the risk of adverse drug reactions.
We have been using lessons from the COVID-19 response to address another biological threat: monkeypox. By leveraging our cutting-edge technology and uniquely skilled personnel, Mirimus was able to launch its monkeypox laboratory developed test (LDT) shortly after the World Health Organization declared monkeypox to be a global health emergency. The test is a highly sensitive and specific PCR assay with the ability to detect very low concentrations of the virus. Secure online results will be available within only 24 hours of the lab receiving specimens. Testing is critical to identify the extent of an outbreak, contain it, and to ensure patients can get access to treatment.
